St Pharm

St Pharm, founded in 1983, is a specialized contract development and manufacturing organization (CDMO) operating within the pharmaceutical and healthcare sectors. The company focuses on advanced gene therapy technologies, specifically providing high-quality oligonucleotide and mRNA manufacturing services. By leveraging over three decades of industry experience, St Pharm delivers comprehensive solutions ranging from small molecule production to complex clinical research support for global pharmaceutical partners.

The organization maintains a robust operational footprint with 2 locations and a workforce of 500-1,000 employees. This scale allows St Pharm to provide end-to-end development capabilities, ensuring rigorous quality control and technical precision in every project. Their technical infrastructure supports the entire lifecycle of drug development, from initial research phases to large-scale commercial manufacturing, catering to the evolving needs of biotechnology firms and research institutions worldwide.

St Pharm continues to distinguish itself through innovation in the biotechnology landscape, focusing on high-growth areas like gene therapy. The company’s commitment to technical excellence and strategic partnerships positions it as a key player in the global CDMO market. Meet St Pharm's team to learn more about the leadership and technical expertise driving their operations. Their dedication to advancing pharmaceutical manufacturing ensures they remain a reliable partner for organizations seeking specialized development and production services in the competitive healthcare industry.